The first total synthesis of potent human chymase inhibitor SPF32629B via regioselective bromination and O-acylation strategy

Tetrahedron Letters

Volumn 51, Issue 20, 2010, Pages 2768-2770

  Vegi, Srinivasa Rao ^a,b   Boovanahalli, Shanthaveerappa K ^a   Patro, Balaram ^a   Mukkanti, K ^b  

^a GVK BIOSCIENCES PVT LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE INHIBITOR; SPF 32629B; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; BROMINATION; CARBOXYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; STEREOCHEMISTRY; X RAY ANALYSIS;

EID: 77950690807     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.03.091     Document Type: Article

References (27)

1. Shimatani, T.; Hosoya, Y. Japanese Patent JP 2004067584, 2004; Chem. Abstr. 2004, 140, 216278.
2. Shimatani T., Hosotani N., Ohnishi M., Kumagai K., and Saji I. J. Antibiot. 59 (2006) 29-34
3. Muto T., and Fukami H. IDrugs 5 (2002) 1141-1150
4. Akahoshi F. Drugs Future 27 (2002) 765-770
5. Doggrell S.A., and Wanstall J.C. Expert Opin. Investig. Drugs 12 (2003) 1429-1432
6. Fukami H., Okunishi H., and Miyazaki M. Curr. Pharm. Des. 4 (1998) 439-453
7. Tomimori Y., Muto T., Fukami H., Saito K., Horikawa C., Tsuruoka N., Saito M., Sugiura N., Yamashiro K., Sumida M., Kakutani S., and Fukuda Y. Lab. Invest. 82 (2002) 789-794
8. Watanabe N., Tomimori Y., Saito K., Miura K., Wada A., Tsudzuki M., and Fukuda Y. Int. Arch. Allergy Immunol. 128 (2002) 229-234
9. Kokkonen J.O., Lindstedt K.A., and Kovanen P.T. Circulation 107 (2003) 2522-2524
10. Matsumoto T., Wada A., Tsutamoto T., Ohnishi M., Isono T., and Kinoshita M. Circulation 107 (2003) 2555-2558
11. Kanemitsu H., Takai S., Tsuneyoshi H., Nishina T., Yoshikawa K., Miyazaki M., Ikeda T., and Komeda M. Hypertens. Res. 29 (2006) 57-64
12. Tomimori Y., Muto T., Saito K., Tanaka T., Maruoka H., Sumida M., Fukami H., and Fukuda Y. Eur. J. Pharmacol. 478 (2003) 179-185
13. Sakaguchi M., Takai S., Jin D., Okamoto Y., Muramatsu M., Kim S., and Miyazaki M. Eur. J. Pharmacol. 493 (2004) 173-176
14. Takai S., Jin D., Muramatsu M., Okamoto Y., and Miyazaki M. Eur. J. Pharmacol. 501 (2004) 1-8
15. Aoyama Y. Expert Opin. Ther. Patents 11 (2001) 1423-1428
16. Akahoshi F. Curr. Pharm. Des. 9 (2003) 1191-1199
17. Akahoshi F., Ashimori A., Sakashita H., Yoshimura T., Imada T., Nakajima M., Mitsutomi N., Kuwahara S., Ohtsuka T., Fukaya C., Miyazaki M., and Nakamura N. J. Med. Chem. 44 (2001) 1286-1296
18. Akahoshi F., Ashimori A., Sakashita H., Yoshimura T., Eda M., Imada T., Nakajima M., Mitsutomi N., Kuwahara S., Ohtsuka T., Fukaya C., Miyazaki M., and Nakamura N. J. Med. Chem. 44 (2001) 1297-1304
19. Masaki H., Mizuno Y., Tatui A., Murakami A., Koide Y., Satoh S., and Takahashi A. Bioorg. Med. Chem. Lett. 13 (2003) 4085-4088
20. Tanaka T., Muto T., Maruoka H., Imajo S., Fukami H., Tomimori Y., Fukuda Y., and Nakatsuka T. Bioorg. Med. Chem. Lett. 17 (2007) 3431-3434
21. Iijima K., Katada J., and Hayashi Y. Bioorg. Med. Chem. Lett. 9 (1999) 413-418
22. Koide Y., Tatsui A., Hasegawa T., Murakami A., Satoh S., Yamada H., Kazayama S.-I., and Takahashi A. Bioorg. Med. Chem. Lett. 13 (2003) 25-29
23. Groutas W.C., Schechter N.M., He S., Yu H., Huang P., and Tu. Bioorg. Med. Chem. Lett. 9 (1999) 2199-2204
24. Vegi S.R., Boovanahalli S.K., Sharma A.P., and Mukkanti K. Tetrahedron Lett. 49 (2008) 6297-6299
25. Ochiai E. J. Org. Chem. 18 (1953) 534-551
26. R = 8.69 and 12.57.
27. 3. Further details of the crystal structure investigation can be obtained from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK (CCDC Deposition No. 759752).